Ongoing mini-HTAs in Norway in March 2024

In March 2024, the following ongoing mini-HTA assessments for diagnostic imaging, e-health, endoscopic procedures, IVD, neuromodulation, peripheral vascular, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway: 

• Robot-assisted ultrasound on pregnant women;
• User-controlled epilepsy follow-up with patient-reported data;
• Digital psychoeducational treatment program for adults with attention deficit hyperactivity disorder;
• Use of the artificial intelligence application BoneView (by Gleamer) for analysis of diagnostic images in suspected fractures;
• Breathe Better – A digital tool to strengthen the health skills of people with chronic lung disease;
• Endoscopic spine surgery
• Return of intestinal contents in patients with intestinal failure using The Insides System pump;
• DNA methylation of cancer tumors;
• Introduction of a test for the detection of somatic mutations in BRCA 1 and 2 (pilot project under the auspices of NorPreM);
• rTMS as a treatment for refractory long-term pain conditions that do not respond to recommended conventional treatment in the specialist healthcare service;
• Percutaneous, mechanical pulmonary embolectomy for acute pulmonary embolism with the Inari FlowTriever.

The full details in Norwegian can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.